ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 19 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -75.0% | 500 | -75.0% | 0.00% | – |
| Q4 2016 | $12,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $15,000 | -11.8% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $17,000 | +30.8% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $13,000 | -23.5% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $17,000 | +240.0% | 2,000 | +100.0% | 0.00% | – |
| Q3 2015 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | +100.0% | 1,000 | +171.0% | 0.00% | – |
| Q3 2014 | $3,000 | – | 369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 781,292 | $2,039,172 | 1.87% |
| GSA CAPITAL PARTNERS LLP | 88,923 | $232 | 0.02% |
| Glass Jacobson Investment Advisors llc | 12,255 | $31,986 | 0.02% |
| Rathbones Group PLC | 289,803 | $756,386 | 0.01% |
| N.E.W. Advisory Services LLC | 12,960 | $33,826 | 0.01% |
| Virtu Financial LLC | 17,388 | $45 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $14,687 | 0.00% |
| ALGERT GLOBAL LLC | 14,680 | $38 | 0.00% |
| Close Asset Management Ltd | 11,400 | $30 | 0.00% |
| Altshuler Shaham Ltd | 12,847 | $33,408 | 0.00% |